IVF Reads / Personal Fertility Plans for Every Couple

Personal Fertility Plans for Every Couple

M
Written by MayaPublished Updated
AI summary

A fertility plan is a sequence of decisions, not a document about you. In 346 women using natural family planning to conceive with timed intercourse, the cumulative probability of conception was 38% after one cycle, 68% after three, 81% after six and 92% after twelve, and 10.4% of the 346 did not conceive at all; the authors concluded that most couples conceive within six cycles and that thereafter every second couple is probably subfertile or infertile (Gnoth et al, Human Reproduction 2003;18(9):1959-66). Unexplained infertility is a diagnosis of exclusion, and ESHRE's 2023 guideline states that a consensual standardisation of the diagnostic work-up is still lacking; of its 52 recommendations, none were supported by high-quality evidence, one by moderate, nine by low and 31 by very low quality evidence (Guideline Group on Unexplained Infertility, Human Reproduction 2023;38(10):1881-1890).

  • Gnoth et al (Hum Reprod 2003;18(9):1959-66), 346 women using timed intercourse from their first cycle: cumulative probability of conception 38% at one cycle, 68% at three, 81% at six and 92% at twelve cycles; 10.4% never conceived. This is a best-case cohort - couples making optimal use of their fertility with timed intercourse - so it is an upper bound rather than an average.
  • ESHRE's 2023 guideline on unexplained infertility (Hum Reprod 2023;38(10):1881-1890) makes 52 recommendations. None are supported by high-quality evidence: one by moderate, nine by low and 31 by very low quality evidence. It states that unexplained infertility is a diagnosis of exclusion and that a consensual standardisation of the diagnostic work-up is still lacking.
  • ESHRE deems the first-line treatment for unexplained infertility to be IUI in combination with ovarian stimulation - not IVF.
  • Cochrane (Cochrane Database of Systematic Reviews 2023;9:CD003357) on IVF for unexplained subfertility: uncertain whether IVF improves live birth versus expectant management (2 RCTs, 86 women, very low-quality evidence); IVF may improve live birth versus unstimulated IUI (OR 2.47, 95% CI 1.19 to 5.12; 2 RCTs, 156 women, low-quality evidence).
  • Semen analysis reference values are distributions, not a pass mark. The 5th centile values behind the WHO sixth edition are 16 million per mL for concentration, 42% total motility, 30% progressive motility and 4% normal forms, from a cohort of more than 3,500 men whose partners conceived within a year (Campbell et al, Andrology 2021;9(3):817-822).
  • The male evaluation is part of the couple's work-up, and detecting male infertility also flags future health risk for the man (Schlegel et al, AUA/ASRM guideline part I, Fertility and Sterility 2021;115(1):54-61).

How long is it reasonable to keep trying before testing?

The most informative figures come from couples who were timing intercourse deliberately, which makes them a best case rather than an average. Gnoth and colleagues followed 346 women using natural family planning methods to conceive from their first cycle onwards. The cumulative probability of conception was:

  • 38% had conceived after one cycle
  • 68% after three cycles
  • 81% after six cycles
  • 92% after twelve cycles
  • 10.4% of 346 women did not conceive at all

The authors' conclusion is the part worth carrying: most couples conceive within six cycles with timed intercourse, and thereafter every second couple is probably either subfertile or infertile. Read that as a reason to start asking questions at six months of well-timed trying rather than as a deadline - these were couples making optimal use of their fertility, so real-world curves are flatter.

What this article deliberately does not do is give you a referral threshold by age. The thresholds in wide circulation come from a national guideline we could not retrieve at the time of writing, and quoting a rule from memory is exactly how wrong numbers spread. Your own clinician's threshold, and the reason for it, is a fair thing to ask about directly.

Conceived by six cycles with timed intercourse81%Cumulative probability of conception among 346 women using natural family planning to conceive; 92% by twelve cycles and 10.4% did not conceive. A best-case cohort, not a population average.Gnoth C, Godehardt D, Godehardt E, Frank-Herrmann P, Freundl G. Human Reproduction 2003;18(9):1959-66.

What has to be ruled out before anything is called unexplained?

Unexplained infertility is a diagnosis of exclusion. That has a blunt consequence for planning: the label is only as good as the work-up behind it, and ESHRE's 2023 guideline states plainly that a consensual standardisation of that work-up is still lacking. Two couples given the same diagnosis at two clinics may have had different things checked.

So the first question a plan should answer is not which treatment, but what has actually been excluded. The three domains any work-up has to cover are ovulation, tubal and uterine anatomy, and semen. This site covers each in detail separately rather than repeating it here:

On the male side, the AUA and ASRM guideline frames the evaluation as the assessment of the male in an infertile couple - history and physical examination first, then diagnostic testing where indicated. It also records something that rarely reaches the patient: detecting male infertility increases the risk of subsequent health problems for that man. A semen analysis is partly a general health test, which is an argument for doing it early rather than after the woman has been through months of investigation.

How should semen and ovarian reserve numbers change the plan?

Less mechanically than most plans assume, because the reference values are distributions rather than pass marks.

The 5th centile values behind the WHO sixth edition come from a cohort of more than 3,500 men in 12 countries whose partners conceived within twelve months:

  • Sperm concentration 16 million per mL, and total sperm number 39 million per ejaculate, in that cohort
  • Total motility 42% and progressive motility 30%, in the same cohort
  • Normal forms 4%, semen volume 1.4 mL and vitality 54%, from that same cohort

The authors of that dataset state directly that these do not represent distinct limits between fertile and subfertile men, and the sixth edition itself dropped reference thresholds in favour of “decision limits” without proposing any.

Practical consequences for a plan:

  • One result just below a 5th centile is a reason to repeat the test, not to escalate treatment
  • A semen analysis reflects sperm produced over roughly the preceding two months, so it dates from before any recent change
  • Numbers well below the range, or a repeatedly abnormal result, change the plan; a borderline one usually should not

What does the evidence say the next step should be?

For unexplained infertility, ESHRE deems the first-line treatment to be IUI in combination with ovarian stimulation. Not IVF. That ordering is worth knowing before a first consultation, because the gap between it and what gets offered is where a lot of money goes.

The evidence under the whole ladder is weak, and saying so is not hedging. Cochrane's 2023 review of IVF for unexplained subfertility found:

  • Versus expectant management: uncertain whether IVF improves live birth or clinical pregnancy - two RCTs, 86 women, very low-quality evidence
  • Versus unstimulated IUI: IVF may improve live birth (OR 2.47, 95% CI 1.19 to 5.12) - two RCTs, 156 women, low-quality evidence
  • Assuming a 16% live birth rate with unstimulated IUI, the rate with IVF would lie somewhere between 18.5% and 49%

And of ESHRE's 52 recommendations on unexplained infertility, none rest on high-quality evidence: one on moderate-quality, nine on low and 31 on very low. This is a field where the sequence is conventional rather than proven, so a plan that commits to a review point is worth more than one that commits to a protocol.

Sometimes the answer is testing, timing or a simpler treatment. ASRM's committee opinion on optimising natural fertility exists precisely for couples attempting conception who have no evidence of infertility, and that is a real category - not everyone presenting at a clinic needs a cycle.

What should a plan actually commit to in writing?

These are questions to put to a clinician, not things to decide alone. A plan that answers them is auditable; one that does not is a sales sequence.

  • What has been excluded so far, and what has not been checked yet
  • Which single result would change the plan, and in which direction
  • How many attempts at this step before the plan is reviewed, agreed in advance rather than after a failed cycle
  • What the denominator is on any success figure quoted - per cycle started or per transfer, and for which age band and diagnosis
  • What the next step would be if this one does not work, and what it costs
  • Which parts are evidence-based and which are the clinic's preference - a fair question, and ESHRE's own quality ratings make it a reasonable one
  • When you will both sit down and decide whether to continue

Deciding the number of attempts in advance is the item most often skipped and the one that most changes how the months feel. It is easier to agree on two stimulated IUI cycles before starting than to decide after the second has failed.

What the evidence does not establish

Reasonably established:

  • Most couples with timed intercourse conceive within six cycles, and 92% within twelve, in a best-case cohort of 346 women
  • Unexplained infertility is a diagnosis of exclusion, and there is no agreed standard for the work-up behind it
  • ESHRE places stimulated IUI ahead of IVF as first-line treatment for unexplained infertility
  • Semen reference values are distributions from men who conceived, not a boundary between fertile and infertile

Not established:

  • That a personalised plan, as such, produces more live births than standard care. No retrieved study has tested that, and this article makes no such claim
  • The optimal moment to escalate from one step to the next. The Cochrane comparisons rest on 86 and 156 women
  • That stress causes infertility, or that reducing it improves conception. No retrieved source here supports it - support is worth having because treatment is hard
  • That any lifestyle change or supplement substitutes for completing the work-up
  • Referral thresholds by age, which are not asserted here because the guideline stating them could not be retrieved and verified

The honest summary: the value of a plan is not that it is personalised. It is that it names what has been excluded, fixes a review point before the emotional cost of a failed cycle arrives, and states which of its steps are supported by evidence and which are convention.

Not sure what has actually been ruled out?

Ask for the work-up in a list: ovulation, tubes and uterus, semen, and what each result was. A diagnosis of exclusion is only as good as the list behind it.

Keep reading

7 Sources

  1. Gnoth C, Godehardt D, Godehardt E, Frank-Herrmann P, Freundl G. Time to pregnancy: results of the German prospective study and impact on the management of infertility. Human Reproduction. 2003;18(9):1959-66. PMID 12923157. 346 women using natural family planning to conceive from their first cycle onwards, making optimal use of their fertility potential by timed intercourse. Cumulative probability of conception 38%, 68%, 81% and 92% at one, three, six and twelve cycles; 36 of 346 women (10.4%) did not conceive. Authors conclude most couples conceive within six cycles and thereafter every second couple is probably subfertile or infertile. Supports the time-to-pregnancy figures and the best-case caveat. Human Reproduction
  2. Guideline Group on Unexplained Infertility; Romualdi D, Ata B, Bhattacharya S, et al. Evidence-based guideline: unexplained infertility. Human Reproduction. 2023;38(10):1881-1890. PMID 37599566. 52 recommendations. States that unexplained infertility is a diagnosis of exclusion and that a consensual standardisation of the diagnostic work-up is still lacking; that the first-line treatment was deemed to be IUI in combination with ovarian stimulation; and that of the evidence-based recommendations none were supported by high-quality evidence, one by moderate-quality, nine by low-quality and 31 by very low-quality evidence. Supports the exclusion framing, the first-line treatment and the evidence-quality figures. Human Reproduction (ESHRE)
  3. Pandian Z, et al. In vitro fertilisation for unexplained subfertility. Cochrane Database of Systematic Reviews. 2023;9(9):CD003357. PMID 37753821. IVF versus expectant management: uncertain whether IVF improves live birth or clinical pregnancy (2 RCTs, 86 women, very low-quality evidence). IVF versus unstimulated IUI: IVF may improve live birth (OR 2.47, 95% CI 1.19 to 5.12; 2 RCTs, 156 women, low-quality evidence); assuming a 16% live birth rate with unstimulated IUI, the rate with IVF would be 18.5% to 49%. Supports the escalation section and its uncertainty. Cochrane Database of Systematic Reviews
  4. Schlegel PN, Sigman M, Collura B, et al. Diagnosis and treatment of infertility in men: AUA/ASRM guideline part I. Fertility and Sterility. 2021;115(1):54-61. PMID 33309062. Outlines the evaluation of the male in an infertile couple, proceeding from history and physical examination to diagnostic testing where indicated, and records that the detection of male infertility increases the risk of subsequent development of health problems for men. Supports the simultaneous-testing argument and the wider-health point. Fertility and Sterility (AUA/ASRM)
  5. Campbell MJ, Lotti F, Baldi E, et al. Distribution of semen examination results 2020 - A follow up of data collated for the WHO semen analysis manual 2010. Andrology. 2021;9(3):817-822. PMID 33528873. More than 3,500 subjects from 12 countries, prepared for WHO's 2021 distribution of values. 5th centile values for concentration, motility and morphology are 16 x 10^6/mL, 30% progressive motility (42% total motility) and 4% normal forms; the authors state these do not represent distinct limits between fertile and subfertile men. Supports the reference-value figures and the caveat on reading them. Andrology
  6. Boitrelle F, Shah R, Saleh R, et al. The Sixth Edition of the WHO Manual for Human Semen Analysis: A Critical Review and SWOT Analysis. Life. 2021;11(12):1368. PMID 34947899. Table 2 gives the WHO 2021 lower fifth percentiles including semen volume 1.4 mL, total sperm number 39 million per ejaculate, total motility 42%, progressive motility 30%, vitality 54% and normal forms 4%. States that the sixth edition abandons reference thresholds in favour of decision limits, and that no decision limits are proposed for basic, extended or advanced parameters. Supports the full value list and the decision-limits point. Life (Basel)
  7. Practice Committee of the American Society for Reproductive Medicine and the Practice Committee of the Society for Reproductive Endocrinology and Infertility. Optimizing natural fertility: a committee opinion. Fertility and Sterility. 2022;117(1):53-63. PMID 34815068. Cited only for its stated scope: it provides suggestions for optimising the likelihood of achieving pregnancy in couples or individuals attempting conception who have no evidence of infertility, replacing the 2013 document of the same name. Supports the point that pre-investigation optimisation is a recognised category distinct from treatment. Fertility and Sterility (ASRM/SREI)

Frequently asked questions

Common questions on this topic.

Should both partners be tested at the same time?

The AUA and ASRM guideline treats the male evaluation as the assessment of the male in an infertile couple, beginning with history and physical examination and adding diagnostic testing where indicated. Since a semen analysis is quick and also flags wider health risk for the man, there is no evidential reason to hold it back while the female work-up runs.

Can a plan skip IUI and go straight to IVF?

ESHRE's 2023 guideline deems stimulated IUI the first-line treatment for unexplained infertility, so going straight to IVF departs from that. Cochrane found IVF may improve live birth compared with unstimulated IUI (OR 2.47, 95% CI 1.19 to 5.12) on two trials and 156 women, rated low-quality evidence. If IVF is proposed first, the reason should be a specific finding in your work-up rather than a general preference.

How many cycles should a plan include before stopping?

No retrieved source sets a number, and anyone who quotes one confidently is not citing evidence. What the evidence supports is deciding the number in advance and writing it down, because the alternative is deciding it immediately after a failed cycle.

Does a normal semen analysis mean the male side is fine?

Not exactly. The values are 5th centiles from men whose partners conceived within a year, and the authors of that dataset state they do not represent distinct limits between fertile and subfertile men. A result inside the range makes a severe male factor unlikely; it does not exclude a contribution.

If everything comes back normal, what does that actually mean?

It means unexplained infertility, which is a diagnosis of exclusion rather than a finding. ESHRE notes that there is no consensual standardisation of the work-up, so it is worth checking which investigations were done before accepting the label, and asking what has not been looked at.

Will reducing stress improve our chances?

No retrieved source here supports stress as a cause of infertility or stress reduction as a treatment for it. That is not an argument against counselling or support, which are worth having because fertility treatment is genuinely hard - only against presenting them as a way to raise the live birth rate.